MBX Biosciences is a preclinical-stage biotech company committed to creating therapies to treat rare endocrine diseases where there is inadequate treatment available.

MBX’s leadership team has collaborated successfully over several decades to discover, develop and commercialize first-in-class endocrine therapeutics. A distinguishing strength of MBX is world-class proprietary peptide drug discovery.

Biotechnology

Education

MBX Biosciences

MBX Biosciences' headquarters in Carmel, IN, United States

Kent Hawryluk

William Bartlett

Michael A. Dorato

Director, Discovery Pharmacology

Vice President, Quality

Michelle Graham

Matt Gambino

Richard Bartram

Mary Jane Geiger

Patrick Heron

Ed Mathers

Jim Cornelius

Carl L. Gordon

Ora Pescovitz

Tiba Aynechi

Project Manager, Discovery

Description

People (5)

Michael A. Dorato

Michael Hackett

Christine Headley

Jonah Sadowski

Carolyn Fisher Vanluchene

Jobs (3)

Director, Discovery Pharmacology

Vice President, Quality

Project Manager, Discovery